UK pharmacies are implementing a new rebate for the weight loss medication Mounjaro. This adjustment comes after significant apprehension among patients and healthcare providers concerning a potential price increase of up to 170% for the drug. While the newly introduced discount is expected to mitigate the severity of this feared price surge, consumers are advised that the overall cost of Mounjaro will nonetheless experience an uplift. The measure aims to balance market value with patient access, addressing concerns about affordability following initial reports of substantial pricing changes.